FDA, responding to critics, to look at restricting opioids for pain

The Food and Drug Administration (FDA) has announced that it will reassess the way it approaches approvals for opioid medications. On February 5, Robert Califf, M.D., the deputy commissioner for medical products and tobacco, announced that the agency would take a harder line against opioids.

http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fcpu.30113

Source: The Brown University Child and Adolescent Psychopharmacology Update - February 26, 2016 Category: Psychiatry Tags: From the FDA Source Type: research

More News: Children | Food and Drug Administration (FDA) | Pain | Psychiatry | Smokers